BAFNA PHARMACEUTICALS LTD.

NSE : BAFNAPHBSE : 532989ISIN CODE : INE878I01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE86.96-1.04 (-1.18 %)
PREV CLOSE ( ) 88.00
OPEN PRICE ( ) 87.00
BID PRICE (QTY) 86.00 (50)
OFFER PRICE (QTY) 86.94 (198)
VOLUME 141
TODAY'S LOW / HIGH ( )86.96 87.00
52 WK LOW / HIGH ( )76.5 125.55
NSE86.850.35 (+0.4 %)
PREV CLOSE( ) 86.50
OPEN PRICE ( ) 88.70
BID PRICE (QTY) 86.85 (101)
OFFER PRICE (QTY) 86.95 (50)
VOLUME 12235
TODAY'S LOW / HIGH( ) 85.00 88.70
52 WK LOW / HIGH ( )75.9 124.45

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.